Literature DB >> 16136772

Newly diagnosed chronic granulomatous disease in a 53-year-old woman with Crohn disease.

Srinivasan Ramanuja1, Karen M Wolf, Mohammed A Sadat, Stephen J Mahoney, Mary C Dinauer, Robert P Nelson.   

Abstract

BACKGROUND: Chronic granulomatous disease (CGD) is characterized by defective bactericidal activity of white blood cells, specifically, a defect in superoxide production. Patients experience infections, predominantly caused by catalase-positive bacteria and fungal organisms, that may be severe and life-threatening. Most cases of CGD are diagnosed in children; however, it may rarely go undiagnosed until adulthood in individuals with unexplained infections and granulomatous inflammation.
OBJECTIVE: To describe an adult with Crohn disease and recurrent infections who was newly diagnosed as having CGD.
METHODS: A 53-year-old woman with a history of liver abscesses and Crohn disease presented with Burkholderia cepacia pneumonia and required a right middle lobe resection. Nitroblue tetrazolium test results confirmed the diagnosis of CGD, and Western blot analysis revealed the absence of the 47-phagocyte oxidase protein. Levels of Crohn-associated specific antibodies to Saccharomyces cerevisiae and Escherichia coli outer membrane porin C were elevated.
RESULTS: The patient, newly diagnosed as having CGD, was given intravenous trimethoprim-sulfamethoxazole, after which she improved clinically and was discharged from the hospital in stable condition to receive daily oral trimethoprim-sulfamethoxazole treatment.
CONCLUSIONS: The concomitant occurrence of Crohn disease and CGD, both characterized by granulomatous inflammation, is noteworthy. This case study demonstrates that CGD should be considered in adults with recurrent infections, especially those caused by catalase-positive organisms, such as B cepacia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16136772     DOI: 10.1016/S1081-1206(10)61212-4

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  8 in total

Review 1.  Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves.

Authors:  Katharine S Nelson; David B Lewis
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

2.  Two Chronic Granulomatous Disease Diagnosed in Adult Age.

Authors:  Fatma Tokgöz Akyıl; Tülin Sevim; Safa Barış; Emine Aksoy; Dilem Anıl Tokyay; Yasemin Bodur; Oğuz Aktaş
Journal:  Turk Thorac J       Date:  2016-10-01

3.  Antibodies to CBir1 are associated with glycogen storage disease type Ib.

Authors:  Michael K Davis; John F Valentine; David A Weinstein; Steven Polyak
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-07       Impact factor: 2.839

4.  Refractory Burkholderia cepacia bacteraemia from a consolidation pneumonia lasting more than 7 weeks, successfully treated with systemic antibiotics and nebulised meropenem.

Authors:  Bryan Albert Lim; Adelaine Lopez; Joseph Adrian Buensalido
Journal:  BMJ Case Rep       Date:  2019-08-02

Review 5.  Clinical immunology review series: an approach to the patient with recurrent infections in childhood.

Authors:  M A Slatter; A R Gennery
Journal:  Clin Exp Immunol       Date:  2008-03-28       Impact factor: 4.330

6.  An unusual cause of granulomatous disease.

Authors:  Andrew P C McLean-Tooke; Catherine Aldridge; Kimberley Gilmour; Bernard Higgins; Mark Hudson; Gavin P Spickett
Journal:  BMC Clin Pathol       Date:  2007-03-02

7.  Chronic Granulomatous Disease Presenting as Aspergillus Fumigatus Pneumonia in a Previously Healthy Young Woman.

Authors:  David Williams; Dipen Kadaria; Amik Sodhi; Roy Fox; Glenn Williams; Stephen Threlkeld
Journal:  Am J Case Rep       Date:  2017-04-05

8.  Newly diagnosed chronic granulomatous disease in a 44 year old male presenting with recurrent groin cellulitis and colitis.

Authors:  Arthur G Chung; Michael M Cyr; Anne K Ellis
Journal:  Allergy Asthma Clin Immunol       Date:  2013-03-06       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.